NL-OMON22148招募中不适用

Hyaluronic acid versus corticosteroids compared to a placebo in subacromial injections for shoulder cuff inpingement.

Academisch ziekenhuis MaastrichtThe Research Institute Caphri of the University Maastricht0 个研究点目标入组 159 人开始时间: 待定最近更新: 2024年2月28日

试验速览

•Eligible are patients of 18 years of age and older, who consult a physician for pain in the shoulder either at rest or elicited or provoked during movement of the shoulder. They must have a painful arc, with or without a disturbed scapulohumeral movement. The diagnosis is subacromial impingement syndrome.

•Pain lasting less than 6 weeks;
•prior injection with corticosteroids last 3 months, less than 100 degrees range of ante flexion;
•more than 50% restriction of external glenohumeral rotation (compared to the non-affected side);
•steroid or lidocaine allergy; pregnancy or supposed pregnancy; dementia;
•(prior) purulent infection of the shoulder joints;
•tumor, osteoporosis, rheumatoid arthritis (ACR criteria), referred pain from internal organs, or a cervical radicular syndrome as suspected or definite cause for SD;
•stroke, polyneuropathy, multiple sclerosis, polymyalgia, ankylosing spondylitis (modified NY criteria) as suspected or definite cause for SD;
•Whiplash, prior fractures or surgery of the shoulder, upper limb, neck or thorax;
•currently receiving (or needing) treatment for serious behavioral, cognitive or psychiatric disorders.
•Finally, patients who are not able to complete Dutch questionnaires independently and those who are reluctant to adhere to (allocated) treatments or to complete follow-up will be excluded.

发起方

Academisch ziekenhuis MaastrichtThe Research Institute Caphri of the University Maastricht